Indoco Remedies Intrinsic Value
INDOCO • Healthcare
Current Stock Price
₹192.88
Primary Intrinsic Value
₹482.20
Market Cap
₹347.2 Cr
+141.9%
Upside
Median Value
₹466.53
Value Range
₹386 - ₹482
Assessment
Trading Below Calculated Value
Safety Margin
58.7%
INDOCO Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹482.20 | ₹433.98 - ₹530.42 | +150.0% | Book Value/Share: ₹565.56, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹385.76 | ₹347.18 - ₹424.34 | +100.0% | Revenue/Share: ₹1051.11, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹385.76 | ₹347.18 - ₹424.34 | +100.0% | EBITDA: ₹120.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹466.53 | ₹373.22 - ₹559.84 | +141.9% | CF Growth: 3.7%, Discount: 15% |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
INDOCO Intrinsic Value Analysis
What is the intrinsic value of INDOCO?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Indoco Remedies (INDOCO) is ₹466.53 (median value). With the current market price of ₹192.88, this represents a +141.9% variance from our estimated fair value.
The valuation range spans from ₹385.76 to ₹482.20, indicating ₹385.76 - ₹482.20.
Is INDOCO undervalued or overvalued?
Based on our multi-method analysis, Indoco Remedies (INDOCO) appears to be trading below calculated value by approximately 141.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.66 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -3.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.78x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Indoco Remedies
Additional stock information and data for INDOCO
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹95 Cr | ₹-75 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹155 Cr | ₹-61 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹179 Cr | ₹75 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹174 Cr | ₹114 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹82 Cr | ₹49 Cr | Positive Free Cash Flow | 8/10 |